News Focus
News Focus
icon url

PoemStone

09/20/12 7:34 AM

#9121 RE: PoemStone #9120

DYAX. Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html